Karuna Therapeutics Common Stock

Karuna Therapeutics (KRTX) currently reports a common stock of $4K as of December 2023. That compares with $34M in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Karuna Therapeutics's common stock history and peer comparisons.

Karuna Therapeutics's common stock decreased from $34M to $4K — a 100.0% year-over-year decrease (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Karuna Therapeutics reported $4K in common stock as of December 2023. That compares with $34M in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $4K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Karuna Therapeutics, and consider following KRTX for alerts when major investors trade the stock.

Karuna Therapeutics is classified in the Healthcare sector. On common stock, it currently shows $4K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KRTX with unrelated industries.